Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents
NCT00375570
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
254
Enrollment
INDUSTRY
Sponsor class
Conditions
Herpes Labialis
Interventions
DRUG:
ME-609
Sponsor
Medivir